Aphena Pharma to complete expansion of Solid Dose Division by April
Category: #health  By Pankaj Singh  Date: 2021-01-27
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

Aphena Pharma to complete expansion of Solid Dose Division by April

Aphena Pharma Solutions, a pharmaceutical services provider, has reportedly announced the continuous expansion of its Tennessee-based Solid Dose Division worth $21 million. This division is expected to be completed by 1st April 2021.

The expansion, announced in September 2020, includes the takeover of a 500,000-sq.ft. property that was purpose-built for the manufacturing & packaging operations of the FDA. It also represents the expansion of Aphena into biologics, 3rd-party logistics distribution, and cold chain storage, with 47,000-sq.ft. of the cold chain storage currently available.

The latest progress has enabled Aphena to further expand its bottle packaging capacity with the initial installation of 10 high-speed bottling lines for solid-based products such as gel caps, soft gels, caplets, capsules, and tablets. The company is further planning to install 30 more high-speed lines in this new facility in the future, boosting its monthly capacity to nearly 80 million bottles as well as becoming a strategic partner in the industry for pharmaceutical solid dose packaging.

The turnkey bottling services of Aphena include purchasing all the primary & secondary packaging materials such as pharmaceutical bottle labeling with the serialization support. Various configurations and sizes like square bottles are also available. In addition, the company has the capability to efficiently run batches of over 1,000 to 10 million bottles under the cGMP quality systems.

According to Eric Allen, EVP of Sales & Marketing at Aphena, the new facility and bottling lines have set the foundation for the future of the company’s solid dose packaging, enabling it to maintain a capacity level of 50% for new projects as well as surge the capacity requirements to increasingly cater to the customers’ needs.

Aphena Pharma is an industry-leading company that provides contract manufacturing & packaging services for the medical device, consumer health, pharmaceutical, and biologics markets. The company, with two FDA- and DEA-registered U.S. locations, handles suspensions, foams, ointments, creams, gels, liquids, solid dose, and lotion-based products.­

Source credit:

https://www.businesswire.com/news/home/20210126005812/en



About Author

Pankaj Singh

Email: [email protected]   linkdin twitter

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

More News By Pankaj Singh

PCS Software adds new contactless features to expand TMS platform

PCS Software adds new contactless features to expand TMS platform

By Pankaj Singh

  • With this addition, it is now possible for PCS consumers to effectively manage their workflows using their mobile devices
  • Document digitization has...

ODP teams up with Microsoft to support shared & new B2B customers

ODP teams up with Microsoft to support shared & new B2B customers

By Pankaj Singh

The ODP Corporation, an American retail company, has recently announced the expansion of its long-standing relationship with Microsoft. The two companies are planning to boost efficiencies and growth of their shared as...

Gannex reveals positive data from ASC41 clinical study in 20 subjects

Gannex reveals positive data from ASC41 clinical study in 20 subjects

By Pankaj Singh

Ascletis Pharma Inc.’s wholly-owned company, Gannex, has reportedly announced the positive clinical data from its ASC41 trial conducted among overweight and obese subjects. The active metabolite of this liver-tar...